Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters

Neuropsychopharmacology

Volumn 29, Issue 10, 2004, Pages 1790-1799

  Shen, Hao Wei ^a   Hagino, Yoko ^a   Kobayashi, Kidealci ^a   Shinohara Tanaka, Keiko ^a   Ikeda, Kazutaka ^a   Yamamoto, Hideko ^a   Yamamoto, Toshifumi ^b   Lesch, Klaus Peter ^c   Murphy, Dennis L ^d   Hall, F S ^e   Uhl, George R ^e   Sora, Ichiro ^a,e,f  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cocaine reward; Dopamine; in vivo microdialysis; Knockout mice; Monoamine transporter; Serotonin

Indexed keywords

CAUDATE PUTAMEN; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; FLUOXETINE; SEROTONIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; FEMALE; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; REWARD; SEROTONIN BRAIN LEVEL;

ANIMALS; CAUDATE NUCLEUS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; EXTRACELLULAR SPACE; FLUOXETINE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRODIALYSIS; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; PIPERAZINES; PREFRONTAL CORTEX; PUTAMEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STEREOTAXIC TECHNIQUES;

EID: 5044225659     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300476     Document Type: Article

References (48)

1. Baker DA, Tran-Nguyen TL, Fuchs RA, Neisewander JL (2001). Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats. Psychopharmacology (Berl) 155: 18-26.
2. Bardo MT (1998). Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol 12: 37-67.
3. Budygin EA, John CE, Mateo Y, Jones SR (2002). Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice. J Neurosci 22: RC222.
4. Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G (2001). Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 21(RC141): 141-144.
5. Cunningham KA, Callahan PM (1991). Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology (Berl) 104: 177-180.
6. Di Chiara G, Tanda GL, Frau R, Carboni E (1992). Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers. Neurochem Int 20(Suppl): 231S-235S.
7. Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, Janowsky A (1999). Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J Pharmacol Exp Ther 289: 877-885.
8. Faraj BA, Olkowski ZL, Jackson RT (1994). Active [3H]-dopamine uptake by human lymphocytes: correlates with serotonin transporter activity. Pharmacology 48: 320-327.
9. Franklin KBJ, Paxinos G (1997). The Mouse Brain in Stereotaxic Coordinates. Academic: San Diego.
10. Freed C, Revay R, Vaughan RA, Kriek E, Grant S, Uhl GR et al (1995). Dopamine transporter immunoreactivity in rat brain. J Comp Neurol 359: 340-349.
11. Garzon M, Pickel VM (2001). Plasmalemmal mu-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area. Synapse 41: 311-328.
12. Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, Caron MG (1994). Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 269: 15985-15988.
13. Goeders NE, Dworkin SI, Smith JE (1986). Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex. Pharmacol Biochem Behav 24: 1429-1440.
14. Goeders NE, Smith JE (1983). Cortical dopaminergic involvement in cocaine reinforcement. Science 221: 773-775.
15. Gong W, Neill D, Justice Jr JB (1996). Conditioned place preference and locomotor activation produced by injection of psychostimulants into ventral pallidum. Brain Res 707: 64-74.
16. Gong W, Neill D, Justice Jr JB (1997). 6-Hydroxydopamine lesion of ventral pallidum blocks acquisition of place preference conditioning to cocaine. Brain Res 754: 103-112.
17. Gu H, Wall SC, Rudnick G (1994). Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269: 7124-7130.
18. Hall FS, Li XF, Sora I, Xu F, Caron M, Lesch KP et al (2002). Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 115: 153-161.
19. Jog MS, Kubota Y, Connolly CI, Hillegaart V, Graybiel AM (1999). Building neural representations of habits. Science 286: 1745-1749.
20. Kelley AE, Berridge KC (2002). The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22: 3306-3311.
21. Kirkpatrick P (2001). A rewarding double act. Nature Reviews Neuroscience 3: 284.
22. Kleven M, Ybema C, Carilla E, Hamon M, Koek W (1995). Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin following chronic ethanol consumption in the rat: evidence for the involvement of 5-HT1A receptors in ethanol dependence. Eur J Pharmacol 281: 219-228.
23. Kleven MS, Koek W (1998). Discriminative stimulus properties of cocaine: enhancement by monoamine reuptake blockers. J Pharmacol Exp Tker 284: 1015-1025.
24. Koob GF, Nestler EJ (1997). The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 9: 482-497.
25. Kuhar MJ, Ritz MC, Boja JW (1991). The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14: 299-302.
26. Lee K, Kornetsky C (1998). Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation. Pharmacol Biochem Behav 60: 539-544.
27. Liu Y, Edwards RH (1997). The role of vesicular transport proteins in synaptic transmission and neural degeneration. Annu Rev Neurosci 20: 125-156.
28. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002). Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22: 389-395.
29. Pan Y, Gembom E, Peng W, Lesch KP, Mossner R, Simantov R (2001). Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice. Brain Res Dev Brain Res 126: 125-129.
30. Parsons LH, Weiss F, Koob GF (1998). SerotoninlB receptor stimulation enhances cocaine reinforcement. J Neurosci 18: 10078-10089.
31. Ranaldi R, Wise RA (2001). Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine. J Neurosci 21: 5841-5846.
32. Reynolds JN, Hyland BI, Wickens JR (2001). A cellular mechanism of reward-related learning. Nature 413: 67-70.
33. Roberts DC, Koob GF (1982). Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav 17: 901-904.
34. Rocha BA, Ator R, Emmett-Oglesby MW, Hen R (1997). Intravenous cocaine self-administration in mice lacking 5-HT1B receptors. Pharmacol Biochem Behav 57: 407-412.
35. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B et al (1998). Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1: 132-137.
36. Sasaki-Adams DM, Kelley AE (2001). Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior. Neuropsychopharmacology 25: 440-452.
37. Sesack SR, Hawrylak VA, Malus C, Guido MA, Levey AI (1998). Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18: 2697-2708.
38. Shippenberg TS, Hen R, He M (2000). Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the Serotonin(1B) receptor. J Neurochem 75: 258-265.
39. Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB et al (2001). Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98: 5300-5305.
40. Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R et al (1998). Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 95: 7699-7704.
41. Tanda G, Pontieri FE, Frau R, Di Chiara G (1997). Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9: 2077-2085.
42. Tzschentke TM (2001). Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63: 241-320.
43. Uhl GR, Hall FS, Sora I (2002). Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7: 21-26.
44. Uhl GR, Li S, Takahashi N, Itokawa K, Lin Z, Hazama M et al (2000). The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins. Faseb J 14: 2459-2465.
45. White NM, McDonald RJ (2002). Multiple parallel memory systems in the brain of the rat. Neurobiol Learn Mem 77: 125-184.
46. Wise RA (1989). Opiate reward: sites and substrates. Neurosci Biobehav Rev 13: 129-133.
47. Yamamoto BK, Novotney S (1998). Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 71: 274-280.
48. Zhou FC, Lesch KP, Murphy DL (2002). Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res 942: 109-119.